Big Pharma Is Developing Cannabis-Based Painkillers

The success that medical cannabis has seen in the past five years has prompted researchers and scientists to dive deep into the plant’s medicinal properties and uses, one of the most important being the aid that cannabis can provide for victims of opioid addiction and chronic pain. 

• Related Story: Got The End-Of-Summer Blues? Here’s How Marijuana Can Help

The pharmaceutical industry has millions of dollars to lose from these new developments where people have begun to replace opioids with medical marijuana to treat the symptoms of a plethora of different diseases. 

Several publications claim that pharmaceutical industries are gearing up for these new developments, looking into other options where they can use cannabis as a way of replacing opioids and also avoiding the spread of the opioid crisis that’s taking place in America. It may take a while for this to happen though, especially considering the government’s history with the drug and the fact that marijuana is still considered a schedule I type of drug.

• Related Story: Opioid Crisis Is Declared A National Emergency 8 Years Too Late

While marijuana can be a good way and a really great option of preventing an even larger spread of the opioid crisis and for providing relief for patients that suffer from different kinds of diseases, it may still not be enough for more serious types of issues that will surely need the strength of opioids to help patients cope with their more serious symptoms.